Introduction {#Sec1}
============

Coronavirus disease 2019 (COVID-19) pandemic has imposed an unprecedented challenge to global healthcare systems, societies, and governments \[[@CR1]\]. As of May 16, 2020, the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2, causative pathogen for COVID-19) has been detected in every country, with more than 4.6 million confirmed cases and a death toll exceeding 300,000 worldwide \[[@CR2]\]. Furthermore, recent pandemic model projections estimate that COVID-19 could result in \~ 40 million deaths globally this year, if no interventions are implemented \[[@CR3]\]. To date, in the absence of efficacious pharmaceutical measures for prevention or treatment, the principal strategy to control COVID-19 has focused on community-based, non-pharmaceutical interventions (NPIs) \[[@CR4]\]. These NPIs typically include a package of mitigation and suppression measures (e.g., case-based isolation, shielding of vulnerable groups, school closures, restricting public events and lockdowns), that aim to minimize person-to-person transmissions of SARS-CoV-2 through social distancing \[[@CR5]\].

While NPIs are effective (e.g., in blunting the peak of the epidemic, preventing health systems overload and reducing incidence) \[[@CR4], [@CR6], [@CR7]\], these long-term measures are also associated with significant unemployment, economic hardship and social disruption (with surveys from resource-poor settings showing an average fall in income by 70% and consumption expenditure by 30%) \[[@CR8]\]. There is a growing concern whether these prolonged interventions are sustainable given the widespread disparities in economic resilience and health sector capacities globally \[[@CR9]\]. As a result, many countries worldwide are currently considering to lift the lockdowns---increasing the likelihood of disease resurgence. In this regard, dynamic NPIs with intervals of relaxed social distancing, may serve as a realistic alternative to achieve the NPI goals, with minimal adverse socioeconomic consequences. However, it remains unclear (1) what should be the frequency and duration of such dynamic NPIs, (2) what should be the ideal "break" when interventions can be relaxed temporarily before case numbers resurge, and (3) which dynamic NPI strategy should be adapted globally across regions with diverse health and economic infrastructures. Addressing these issues is essential to devise feasible, context-specific policies to prevent collapse of healthcare systems, reduce premature deaths and minimize detrimental impacts on national economies associated with prolonged continuous NPIs.

To address these uncertainties, we have employed a transmission dynamic model comparing sixteen countries that vary in setting and income groupings. Our key aims were to: (1) calculate age-standardized estimates of case-severity and fatality in included countries; (2) estimate the impact of an uncontrolled course of the pandemic in each country, given the current resources of their health systems (counterfactual), (3) compare continuous versus intermittent combinations of mitigation/suppression and relaxation strategies, over an 18-month period (i.e., optimistic timeline for an efficacious vaccine to be developed \[[@CR10]\]); and (4) identify strategies that help keep the number of projected cases requiring critical care within a manageable limit, while also considering a feasible duration of these interventions.

Methods {#Sec2}
=======

This study was conducted according to the to the TRIPOD reporting guideline \[[@CR11]\] for prediction modelling studies (Supplementary Appendix 1).

Study design, source of data and study settings {#Sec3}
-----------------------------------------------

We have employed a multivariate prediction model to describe COVID-19 transmission dynamics under various NPIs. Since the distributions of age and underlying co-morbidities may differ importantly by country, region and economic status \[[@CR4]\] we have hypothesised that the predicted mortality impacts for NPI strategies will differ importantly. Therefore, for this current study, we have considered several circumstances. First, we used age-standardized clinical dynamic estimates to model the epidemic trajectories in 16 different countries (which comprise roughly a quarter of the global population), by accessing available country-specific age structure data. Second, we selected these countries from diverse geographical regions: Western Europe (The Netherlands, Belgium), South America (Chile, Colombia), North America (Mexico), Africa (South Africa, Nigeria, Ethiopia, Tanzania, Uganda), South Asia (India, Bangladesh, Pakistan Sri Lanka), West Asia (Yemen), and the Pacific (Australia). Third, these countries also represent all income categories equally, as defined by the World Bank \[[@CR12]\]: four countries in every high (HIC), higher-middle (HMIC), lower-middle (LMIC) and low income (LIC) groups, respectively.

Intervention scenarios, predictors and outcomes {#Sec4}
-----------------------------------------------

We considered case isolation at home, voluntary home quarantine, closure of schools and universities, and social distancing of the entire population as physical distancing measures. We defined the study interventions scenarios based on reduction of the reproduction number during the duration of intervention (*R*). For this, we assumed a basic reproduction number \[[@CR13]\] (*R*~0~, the average number of secondary infections arising from a typical single infection in a completely susceptible population) of 2.2 for uncontrolled spread of COVID-19, and effective reproduction numbers (*R*, average number of secondary cases per infectious case in presence of control measures and a partially immune population) of 0.8 and 0.5 for mitigation and suppression interventions, respectively. These assumptions were based on recent work by Jarvis et al. \[[@CR14]\] who reported a 73% reduction in the average daily number of contacts observed per participant for physical distancing measures. This corresponded to a pre-intervention *R*~0~ value of 2.6 to reduce to a post-intervention *R* value of 0.62 (95% confidence interval: 0.37--0.89) following strict suppression measures. Even though the exact relationship between changes in the number of social contacts and *R*~0~ remains unclear, we used these findings as the rationale to calculate our study's effective *R* values of 0.5 and 0.8 for the interventions. These numbers are in agreement with recent estimates for several European countries and arguably reflect the expected effects of a somewhat relaxed and more stringent lockdown \[[@CR15]\].

Based on this approach, or each country, the following intervention scenarios were considered: (1) no intervention (i.e., counterfactual scenario), (2) consecutive cycles of mitigation (a combination of measures, such as general social distancing measures, hygiene rules, case-based isolation, shielding of vulnerable groups, school closures or restricting of large public events; target *R* = 0.8), followed by a relaxation period (comprising of case-based home isolation of positive cases and shielding of vulnerable groups), (3) consecutive cycles of suppression (additional measures of strict physical distancing, including lockdowns; target *R* = 0.5) followed by a relaxation period (as defined above), and (4) a continuous suppression measure with no relaxation.

In the absence of intervention, the assumed parameters for transmission dynamics yielded a characteristic rise-and-fall timescale of infections of about 50 days, which we set to be the illustrative duration of intervention. Choosing a slightly longer period (e.g. 60 days) yielded similar outcomes. The duration of breaks between interventions needs to be less than the intervention period for the interventions to be effective; therefore, we set the break duration to be 30 days. When to intervene was determined by the initial fraction of the population that was infected. For example, if the fraction was on the order of 1 part in 10,000 (or more), we set the initiation point for the intervention at Day 20. However, if the fraction was on the order of 1 part in 100,000 to 1 million, we set the initiation point as Day 30. Similarly, if the fraction was on the order of 1 part in 10 million, we set this at Day 50. Changes in the initial fraction simply shift the curves back and forth in time without altering their shapes.

For each country, the outcomes of interest were (1) the number requiring intensive care unit (ICU) beds (primary outcome); and (2) total number of hospitalizations and deaths (secondary outcome), by different scenarios of NPIs, and within a time horizon of 18 months. We prioritized ICU care needs as the main outcome since this healthcare component is in short supply in many resource-limited settings, and therefore, is a major determinant for adverse COVID-19 outcomes.

Statistical methods for model calibration and age-standardization {#Sec5}
-----------------------------------------------------------------

The analyses were based on a standard susceptible-exposed-infected-recovered (SEIR) compartmental model \[[@CR16]\] to describe the transmission of SARS-CoV-2 in 16 countries under various NPI scenarios. The model considered additional compartments for hospitalization and ICU demand. Susceptible individuals *S* are infected by infectious individuals *I* at a rate *β*. After an incubation period of 1/*σ* = 5·2 days \[[@CR17]\], exposed individuals *E* becomes infectious *I*, and either clear the infection at a rate *γ* or progress to severe infection *P* with probability *f*~*P*~. The infectious period is taken to be 1/*γ* = 2·3 days, corresponding to a serial interval and generation time of 1/*σ* + 1/*γ* = 7·5 days \[[@CR17]\]. The quantity *f*~*P*~ is the proportion of infections that require hospitalization, for which we obtained age-specific estimates from a recent analysis of COVID-19 cases in China \[[@CR18]\].

We applied these age-specific estimates to each individual country's population to get country-specific age-standardized proportion of infections that require hospitalization. We considered the delay between severe infection and hospitalization is 1/*ω* = 2·7 days \[[@CR4]\]. Severely infected individuals *P* enter the hospital as *H*, after which they either leave the hospital at a rate *κ* or enter the ICU with probability *f*~*U*~. Age-stratified proportions of hospitalized cases requiring ICU care (*f*~*U*~) were based on the Imperial College COVID-19 Response Team's Report \[[@CR4]\], and then standardized according to each country's population age structure. The quantity 1/*κ* is the duration of non-ICU hospital stays, which we considered 8 days \[[@CR4]\]. Patients *U* stay in ICU for 1/*δ* = 8 days \[[@CR4]\], after which a fraction of them die (*f*~*D*~). The age-specific infectious fatality rate (IFR) were obtained from Verity et al. \[[@CR18]\]. Those were subsequently applied to individual country's population to get country-specific age-standardized IFRs (Supplementary Tables S1--S16). IFR is the product of *f*~*P*~, *f*~*U*~, and *f*~*D*~. The basic reproduction number is *R*~0~ = *βN*/*γ* = 2·2 \[[@CR17], [@CR19], [@CR20]\], with *N* being the total population size of the country. The set of coupled ordinary differential equations that underpin our model are presented in the Box [1](#Tab1){ref-type="table"}. These equations in the SEIR model were solved numerically using the *solve_ivp* package in the Python programming language suite \[[@CR21]\]; plots were created using the *matplotlib* graphics package \[[@CR22]\].Box 1Equations used in SEIR compartmental model$\documentclass[12pt]{minimal}
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Results {#Sec6}
=======

Country-specific characteristics and clinical dynamics {#Sec7}
------------------------------------------------------

*Demographic and health system-related characteristics* Table [1](#Tab2){ref-type="table"} presents a summary of the demographic and health system-related characteristics for the included countries, grouped by their respective income levels. Briefly, the countries varied in population size (ranging from 11,539,326 in Belgium to 1,366,417,755 in India). The first cases were identified in a much later date in the LICs (\~ late February--early March, 2020) compared to HIC countries such as Australia, the Netherlands and Belgium. Additionally, there were significant differences across countries with respect to healthcare infrastructure. For example, in the majority of LICs and LMICs, available hospital and ICU beds were \< 1 bed per 1000 population and \< 1 bed per 100,000 population, respectively (Table [1](#Tab2){ref-type="table"}).

Table 1Key demographic and health system-related characteristics of the 16 included countriesSize of populationNumber of initial infections (as of 1 April 2020)^a^Date of first caseHospital beds per 1000 population^b^Total hospital bedsTotal ICU beds^c^ICU beds per 100,000 populationHigh-income Australia25,203,200961825 January 20203.895,77222008.7 Belgium11,539,32611,89904 February 20206.271,544190016.5 Chile18,952,035244903 March 20202.241,69410005.3 The Netherlands17,097,12311,75027 February 20204.780,35611506.7Upper-middle income Colombia50,339,44370206 March 20201.575,509560011.1 Mexico127,575,52899328 February 20201.5191,36330002.4 South Africa58,558,267132605 March 20202.5146,39615002.6 Sri Lanka21,323,73411227 January 20203.676,7655192.4Lower-middle income Bangladesh163,046,1734908 March 20200.8130,43711740.7 India1,366,417,755125130 January 20200.91,229,77629,9972.2 Nigeria200,963,60311127 February 20200.5100,4821280.1 Pakistan216,565,317186526 February 20200.6129,93931421.5Low-income Afghanistan38,041,75716624 February 20200.519,0211000.3 Burkina Faso20,321,38324609 March 20200.48,129500.2 Tanzania58,005,4611916 March 20200.740,604380.1 Uganda44,269,5873320 March 20200.522,135550.1*ICU* intensive care unit^a^Taken from various country-specific reports^b^Taken from The World Bank Data on hospital bed \[[@CR23]\]^c^Taken from various country-specific reports

*Age-standardized estimates of case-severity and fatality* Table [2](#Tab3){ref-type="table"} summarizes various COVID-19 relevant clinical dynamics estimated for each of the 16 included countries. Briefly, proportion of infected individuals who require hospitalization ranged from 1.61% in Uganda to 6.12% in the Netherlands, with higher proportions observed in HIC and UMICs compared to the other country categories. This pattern was similar for the proportion of hospitalized cases requiring critical care (Table [2](#Tab3){ref-type="table"}). IFR estimates were significantly higher in the HICs, compared to LMIC and LICs (range 0.17 in Burkina Faso to 1.13 in Belgium). Table 2Age-standardised estimates for case severity and fatality of COVID-19 for 16 included countriesProportion of infected individuals hospitalised^a^ (%)Proportion of hospitalised cases requiring critical care^b^ (%)Proportion of individuals requiring critical care die^c^ (%)Infection fatality ratio (*IFR*)^d^ (%)High-income Australia5.3429.359.60.93 Belgium6.0131.559.61.13 Chile4.6925.859.50.72 The Netherlands6.1230.659.61.12Upper-middle income Colombia3.9323.359.40.54 Mexico3.5722.359.40.47 South Africa3.0919.159.20.35 Sri Lanka4.3824.259.50.63Lower-middle income Bangladesh3.1019.659.30.36 India3.3520.359.30.41 Nigeria1.9616.359.10.19 Pakistan2.5519.059.20.29Low-income Afghanistan1.8616.459.10.18 Burkina Faso1.8116.059.00.17 Tanzania1.9016.359.00.18 Uganda1.6115.158.90.15All estimates are standardised according to the age structure of the respective country^a^Age-specific proportions of infected individuals hospitalised were taken from Verity et al. \[[@CR18]\]. These proportions were adjusted for under-ascertainment and corrected for demography. We assumed that cases defined as severe would be hospitalised^b^Age-specific proportions of hospitalised cases requiring critical care were taken from Imperial COVID-19 Response Team Report \[[@CR4]\]^c^Age-specific proportions of individuals requiring critical care die were calculated by dividing the IFRs with proportions of infected individuals hospitalised and proportions of hospitalised cases requiring critical care^d^Age-specific *IFR*s were taken from Verity et al. \[[@CR18]\]

Model development and predicted impact of the interventions {#Sec8}
-----------------------------------------------------------

*Impact of uncontrolled or no intervention scenario* In the unlikely scenario of no NPI, the number of cases requiring ICU care would exceed the available capacity significantly for every single country (Fig. [1](#Fig1){ref-type="fig"}). This unmitigated scenario, in aggregate, would also result in 7,840,444 deaths in all 16 countries. This estimate would have been equivalent to approximately 46% of all deaths recorded in these countries in 2017. Additionally, an uncontrolled epidemic would predict 583,738 total deaths in the HIC, 1,026,361 deaths in the HMIC, 6,000,220 deaths in the LMIC, and 230,125 deaths in the LIC settings. The majority of these deaths will occur in India, proportionate to the large population of this country. Under this scenario, the duration of the epidemic will last nearly 200 days in the majority of the included countries (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Impact of dynamic interventions and relaxation on ICU beds requirement in 16 countries over an 18-month period

*Comparing impacts of dynamic cycles of mitigation/suppression and relaxation* Our models predict that simultaneous cycles of 50-day mitigation intervention followed by a 30-day relaxation would likely to reduce the effective reproduction number *R* to 0.8 in all countries. However, this rolling mitigation measure was insufficient to keep the number of patients requiring healthcare below the available critical care capacity (Fig. [1](#Fig1){ref-type="fig"}). In this NPI scenario, the duration of pandemic appeared approximately 12 months in the HIC, and was close to 18 months in the other settings. Additionally, dynamic mitigation interventions were effective at the first 3 months for all the countries, but after the first relaxation, the pandemic would exceed the hospital capacity in all the countries and would result in 3,534,793 deaths. By contrast, we found that dynamic cycles of 50-day suppression followed by a 30-day relaxation, aimed at reducing the effective *R* to 0.5, were suitable for all settings to keep ICU demand within national capacity (Fig. [1](#Fig1){ref-type="fig"}). Since more individuals remain susceptible at the end of each cycle of suppression and relaxation, such approach would result in a longer pandemic, beyond 18 months in all countries; however, global mortality would drop to 131,643 during that period (Fig. [1](#Fig1){ref-type="fig"}).

Estimated impacts of dynamic mitigation and suppression strategies on new infections, hospitalisations and deaths in all 16 countries have been summarised in Table [3](#Tab4){ref-type="table"}. Briefly, the numbers of new infections per day (during the peak of epidemic) were significantly higher for all countries in no and dynamic mitigation intervention scenarios. Both new infections and ICU bed requirements per day (during the peak of epidemic) were significantly lower, especially for low-income settings, for dynamic suppression and relaxation strategy (Table [3](#Tab4){ref-type="table"}). For dynamic mitigation strategies, mortality estimates were 266,835 in HICs, 463,499 in HMICs, 2,700,162 in LMICs, were and 104,297 in LICs. The corresponding estimates for the dynamic suppression strategies were markedly lower: 63,166 in HICs, 32,419 in HMICs, 32,210 in LMICs and 3,848 in LICs (Table [3](#Tab4){ref-type="table"}).

Table 3The estimated impacts of various interventions on COVID-19 outcomes in 16 countriesCountries and income categoriesUncontrolled, no intervention scenarioIntermittent cycles of mitigation and relaxation\
(Effective *R* = 0.8)Intermittent cycles of suppression and relaxation\
(Effective *R* = 0.5)New infections/day during the peakICU bed needs/day during the peakNo. of total deaths over 18 monthsNew infections/day during the peakICU bed needs/day during the peakNo. of total deaths over 18 monthsNew infections/day during the peakICU bed needs/day during the peakNo. of total deaths over 18 monthsHigh-income Australia1,434,63859,803197,746418,64314,79889,09154,748173419,996 Belgium657,88333,213109,785253,15010,67451,15163,135240415,846 Chile1,078,06134,818115,060357,316971653,21018,3514507505 The Netherlands973,77948,724161,147354,37314,83173,38363,412239519,819Upper-middle income Colombia2,862,00069,878230,682988,84120,225104,04030,7305709239 Mexico7,253,642154,507509,7942,082,30837,598228,87953,30886312,047 South Africa3,329,77352,421172,4161,189,73915,67479,09144,3775319094 Sri Lanka1,212,62334,335113,469282,813687651,48978751702039Lower-middle income Bangladesh9,270,170150,503495,4202,427,10433,631226,70036,5974524908 India77,698,7711,414,3844,660,01326,185,375399,9822,093,89387,558121115,379 Nigeria11,426,97397,411319,5982,944,57521,424144,049789451659 Pakistan12,316,925159,636525,1893,653,68240,072235,52086,08484811,264Low-income Afghanistan2,163,08817,64057,851550,669383926,401698943614 Burkina Faso1,155,479891829,228388,909251913,15411,838691080 Tanzania3,297,67327,30889,543809,325574040,75516,653105905 Uganda2,516,78816,35053,503804,079439723,98720,095991249

*Sensitivity analyses* As sensitivity analyses, we found that a single but continuous yearlong mitigation or suppression strategy would be effective to keep the number of patients well below the available hospital capacity (Fig. [2](#Fig2){ref-type="fig"}). In case of suppression, in 3 months, most of the countries would not have any new cases to report. In case of sustained mitigation, countries would require approximately 6.5 months to reach a no-new-case scenario (Fig. [2](#Fig2){ref-type="fig"}). Additionally, dynamic mitigation and suppression interventions implemented for a period of time less than 50 days led to an increase in the number of infections beyond the ICU healthcare capacities. The same was observed for relaxation periods longer than 30 days. Fig. 2Impact of single, sustained mitigation or suppression strategy on total deaths in 16 countries over a 12-month period

Discussion {#Sec9}
==========

In this mathematical modelling study, we have assessed the potential impact of dynamic community-based NPIs, involving sixteen economically diverse countries, as a pragmatic strategy for controlling the COVID-19 pandemic in order to provide a practical illustration of interventions and strategies implemented to reduce the reproduction rate of COVID-19. Our study has several inter-related findings. First, we show that simultaneous cycles of 50-day mitigation (*R* value of 0.8) followed by a 30-day relaxation could provide means to reduce the effective reproduction number, however, will be insufficient to keep the number of patients requiring ICU care within manageable levels. Second, by contrast, we found that dynamic cycles of 50-day suppression (*R* value of 0.5) followed by a 30-day relaxation would be required, for all countries, to keep ICU demands below the national capacities. Third, significant number of new infections and deaths could be prevented if these "rolling" suppression measures can be maintained for an 18-month period, or until a suitable treatment and/or vaccination become available. Finally, a continuous, yearlong suppression strategy may also reduce overall attack rates significantly and appears effective. However, implementation (and socioeconomic sustenance) of such stringent measure could be challenged by its detrimental impacts on population well-being and livelihood.

Our findings may have several explanations. First, despite higher rates of contact across older age groups \[[@CR3]\], we predict a somewhat lower incidence of ICU hospitalisation and deaths in low-income settings. This can be explained, at least partly, by the demographic differences with a relatively younger average age structure of these populations, and absence of integrated death registration system. However, given the significant inequalities in baseline health, testing capabilities and critical care infrastructure across the countries, in reality, a higher overall level of excess deaths are likely in resource-poor settings owing to health systems failure, especially in uncontrolled or mitigation intervention scenarios. Second, it was unsurprising that a more restrictive suppression strategy (*R*: 0.5) in our study reduced ICU hospitalisations and deaths for all countries. This is because a further reduction in the reproductive number secondary to more stringent interventions can maximally reduce the population transmissibility of the SARS-CoV-2 \[[@CR24]\]. Notably, implementation of such strategies also creates a policy dilemma for many low-income countries: how to address the "competing priorities" of preventing COVID-19 associated deaths and public health system failure with the long-term economic collapse and hardship. In this regard, we have observed that in contrast to a long fixed-duration social distancing, dynamic NPIs (that reduce the overall attack rates effectively) may offer a helpful balance.

Third, in our study, dynamic cycles of 50-day suppression followed by a 30-day relaxation were effective to lower the deaths significantly for all countries since both transmissibility and case severity (and by extension, critical care demands) were significantly reduced throughout the 18-month period. Notably, this intermittent combination of strict social distancing, and a relatively relaxed period (with efficient testing, case isolation, contact-tracing and shielding of the vulnerable), may allow populations and the national economies to "breathe" at intervals---a potential that might make this solution more sustainable, especially in resource-poor regions \[[@CR25]\]. The specific durations of these interventions can be defined by specific countries according to their needs and local facilities, what is key is to identify a combination pattern that allows to protect the health of the population not only from COVID-19 but also from economic hardship and mental health issues. Finally, these findings reinforce the value of dynamic social distancing strategies estimated by earlier studies for the UK, Canada and China \[[@CR3], [@CR25], [@CR26]\], and extend these to multiple global regions under various dynamic intervention scenarios.

The strengths and limitations of our study merit careful consideration. First, as restrictive NPIs may need to be maintained worldwide for many months, we have examined the impacts of dynamic NPIs to "switch on" and "switch off" at regular intervals. These measures have shown to be largely unaffected to uncertainties in effective *R* estimates and in the severity of the virus \[[@CR4]\]. Second, NPI strategies only blunt (however prolong) the epidemic cycle, since there is lesser build-up of herd immunity while these interventions are kept in place. If these measures are, however, lifted altogether, a second (potentially more serious) outbreak could occur \[[@CR27]\]. Therefore, in the absence of individual-level data and more detailed country-specific parameters, our study provides an illustrative comparison of different "rolling" strategies to suggest (a) when such measures could be lifted, and (b) for how long. Third, we used the most up-to-date disease transmission parameters \[[@CR4], [@CR17], [@CR18], [@CR20]\] to construct our adaptive models, based on well-established SEIR model of epidemic dynamics for infectious diseases. Fourth, since different interventions are likely to be implemented differentially and may have a heterogeneous effect in multiple locations, we have chosen a broad illustrative target of reducing the reproduction number *R* rather than specific community measures that may differ significantly by context. Fifth, we employed age-standardized estimates of hospitalization and infection-fatality-ratios in countries with diverse demographic structures, and considered countries at various categories of national income, in order to provide useful "context-specific" estimates. Finally, we used *rise-and-fall* timescale of infections (50 days, in the absence of intervention) as the ideal intervention duration and calculated 30-day as the optimal break duration before triggering the next cycle, however specific to each country other combinations could be considered depending the specific settings and availability of resources. In this regard, triggering dynamic interventions based on a specific pre-specified mortality number or rate, as was done in earlier modelling for the UK \[[@CR3]\], would not be optimal for under-developed countries since (a) the health systems are less efficient to ascertain all new cases comprehensively, and (b) a younger demographic would mean that by the time the target mortality threshold is reached for the trigger, the countries have already accrued a significantly large number of cases.

Our study also had several important limitations. In the absence of country-specific, real-time, reproduction numbers for the epidemic, we assumed a constant transmission rate during each modeled cycle. These estimates are likely to vary by a population's adherence to the NPI and the mix of specific measures put in place. In this respect, our chosen effective *R* estimates of 0.8 and 0.5 reflect two scenarios of weaker and stronger reduction in transmission, respectively, which could be achieved through social distancing measures and the interruption of transmission chains (e.g., through ramping up testing, contact tracing, isolation and quarantine and other potential strategies chosen by individual countries). We anticipate that the countries will be able to introduce additional control measures with time that might counterbalance the detrimental effect of decreasing compliance. The age-standardisation analyses were based on public sector surveillance data, which may not be robust for all LMIC and LIC countries, with potentials for underestimation of cases and deaths. Furthermore, given unavailability of relevant data, we were unable to adjust for wider social and economic costs of the dynamic approaches; further studies will be needed to quantify these aspects. Additional factors such as potential seasonal variations, environmental pollutions or structural determinants may influence, at least in part, these interventions, highlighting the need of flexibility in terms of the suitable strategy and combination of interventions that can be implemented in each country. Finally, similar to all modelling studies, our analyses were based on several transmission parameter assumptions. Since some uncertainties exist around the natural history and local transmission dynamics of the SARS-CoV-2, the precise efficacy and optimal duration of the dynamic strategies may differ for other countries and will need to be tailored accordingly.

Our study may have important implications. First, we have reported several findings relevant to COVID-19 management and policy development. We provide an actionable strategy option for COVID-19 control by employing dynamic interventions that could delay the epidemic peak, while allowing time to enhance health systems capacities and efforts to develop therapies or vaccines. These dynamic measures also allow interim periods of relaxation in order to minimise socioeconomic disruptions and maximise population compliance to these stringent suppression measures. However, these should be weighed carefully against costs, any risks imposed to the society, and the social protection available in each setting. Second, these findings also stimulate further relevant research that may involve: (a) more in-depth analyses of detailed natural history of the disease (e.g., including transmissibility in asymptomatic state) based on patient-level data, when available, from various countries \[[@CR28]\], (b) various spatial pathways and patterns of epidemic in different circumstances (e.g., co-morbidity, reinfection) and settings (e.g., urban vs. rural); and (c) targeted modelling studies accounting for genomic susceptibility \[[@CR29]\], social behaviour \[[@CR30]\] and economic diversity \[[@CR3]\].

In conclusion, this multi-country analysis demonstrates that intermittent reductions of *R* below 1 through a potential combination of suppression interventions and relaxation can be a pragmatic strategy for COVID-19 pandemic control. Such a "schedule" of social distancing might be particularly relevant to low-income countries, where a single, prolonged suppression intervention is unsustainable. As a policy option, efficient implementation of dynamic suppression interventions worldwide, therefore, would help: (1) prevent critical care overload and deaths, (2) gain time to develop preventive and clinical measures, and (3) reduce economic hardship globally.
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